WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:41 am Purchase |
2024-09-30 | 13G | Haemonetics Corporation HAE |
WELLINGTON MANAGEMENT GROUP LLP | 4,230,850 8.270% |
962,767 (+29.46%) |
Filing |
| 2024-02-08 10:21 am Sale |
2023-12-29 | 13G | Haemonetics Corporation HAE |
WELLINGTON MANAGEMENT GROUP LLP | 3,268,083 6.440% |
-766,670 (-19.00%) |
Filing |
| 2023-02-06 3:00 pm Sale |
2022-12-30 | 13G | Haemonetics Corporation HAE |
WELLINGTON MANAGEMENT GROUP LLP | 4,034,753 7.970% |
-1,502,785 (-27.14%) |
Filing |
| 2022-02-10 07:48 am Purchase |
2022-01-31 | 13G | Haemonetics Corporation HAE |
WELLINGTON MANAGEMENT GROUP LLP | 5,537,538 10.830% |
447,237 (+8.79%) |
Filing |
| 2022-02-04 09:27 am Purchase |
2021-12-31 | 13G | Haemonetics Corporation HAE |
WELLINGTON MANAGEMENT GROUP LLP | 5,090,301 9.960% |
2,837,909 (+126.00%) |
Filing |